#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4340	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2691	476.9	0	.	n	.	0	C451T	SNP	451	451	C	1059	1059	T	605	T,C	291,255	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4340	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2691	476.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1792	1792	C	606	C,T	549,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4340	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2691	476.9	0	HET	.	.	.	C207T	.	207	207	C	815	815	C	607	C,T	427,112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4094	534.1	0	.	n	.	0	T695C	SNP	695	695	T	1239	1239	C	571	C,A,T	503,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4094	534.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2515	2515	C	658	C	596	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4094	534.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2589	2589	A	654	A,T	588,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4094	534.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3141	3141	C	617	C,T,A,G	543,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4094	534.1	0	HET	.	.	.	A1638G	.	1638	1638	A	2182	2182	A	693	A,G	508,123	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	602	folP	855	855	100.0	folP.l6.c17.ctg.1	1901	94.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1171	1173	AGC	133;133;135	A;G;C,T	115;119;120,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1428	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3960	108.0	1	SNP	p	S91F	1	.	.	271	273	TTC	899	901	TTC	124;123;123	T;T;C	104;107;109	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1428	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3960	108.0	1	SNP	p	D95G	1	.	.	283	285	GGC	911	913	GGC	120;121;120	G;G;C	111;108;107	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1428	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3960	108.0	1	SNP	p	G95N	0	.	.	283	285	GGC	911	913	GGC	120;121;120	G;G;C	111;108;107	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	604	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1802	100.0	1	SNP	p	G45D	0	.	.	133	135	GGC	733	735	GGC	148;148;150	G;G;C	136;133;138	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	430	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1639	78.6	0	.	n	.	0	A197.	DEL	197	197	A	863	863	A	171	A	153	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1734	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	144.3	1	SNP	p	D86N	0	.	.	256	258	GAC	938	940	GAC	174;174;174	G,A;A;C	140,1;142;144	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1734	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	144.3	1	SNP	p	S87R	1	.	.	259	261	CGT	941	943	CGT	172;172;173	C;G;T,G,C	148;149;145,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1734	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	144.3	1	SNP	p	R87W	0	.	.	259	261	CGT	941	943	CGT	172;172;173	C;G;T,G,C	148;149;145,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1734	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	144.3	1	SNP	p	R87I	0	.	.	259	261	CGT	941	943	CGT	172;172;173	C;G;T,G,C	148;149;145,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1734	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	144.3	1	SNP	p	S88P	0	.	.	262	264	TCC	944	946	TCC	174;174;175	T;C;C	146;147;150	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1182	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3100	113.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1810	1812	GGC	126;126;126	G;G;C	114;112;114	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1542	1544	GCC	141;143;144	G;C;C	126;127;128	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1545	1547	ATG	144;144;144	A;T;G	134;132;127	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1557	1559	ACC	147;147;148	A;C;C	132;128;133	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1557	1559	ACC	147;147;148	A;C;C	132;128;133	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2058	2060	ACC	163;163;163	A;C;C	152;145;147	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2112	2114	GCG	167;168;168	G;C;G	151;150;153	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2112	2114	GCG	167;168;168	G;C;G	151;150;153	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2235	2237	GGT	145;145;145	G;G;T	132;130;131	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2244	2246	AGC	147;147;147	A,C;G;C,T,G	128,1;128;125,1,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1098	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3015	108.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2262	2264	CCG	142;142;144	C;C;G	121;124;123	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1474	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3636	121.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1973	1975	CCG	129;131;132	C;C;G	107;109;109	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	734	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2367	93.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	842	842	C	110	C,T	103,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	296	91.0	porB1a.l15.c4.ctg.1	1536	25.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1265	1267	AAT	20;20;20	A;A;T	17;18;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	296	91.0	porB1a.l15.c4.ctg.1	1536	25.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1268	1270	AAT	20;20;20	A;A;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	296	91.0	porB1a.l15.c4.ctg.1	1536	25.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1292	1294	GCA	19;19;19	G;C;AC,A	16;16;15,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	296	91.0	porB1a.l15.c4.ctg.1	1536	25.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1315	1317	GTA	17;17;16	G;T;A	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	296	91.0	porB1a.l15.c4.ctg.1	1536	25.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1324	1324	A	16	A	15	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	886	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2127	124.3	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1183	1185	AGA	164;164;164	A,G;G;A	147,1;146;148	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	886	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2127	124.3	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1204	1206	GGT	160;160;160	G;G;T	147;146;149	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	886	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2127	124.3	1	SNP	p	G120K	1	.	.	358	360	AAG	913	915	AAG	177;177;177	A;A,C;G	161;161,1;159	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	886	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2127	124.3	1	SNP	p	A121N	1	.	.	361	363	AAC	916	918	AAC	177;175;175	A;A;C	157;158;159	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	886	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2127	124.3	1	SNP	p	N121D	0	.	.	361	363	AAC	916	918	AAC	177;175;175	A;A;C	157;158;159	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2916	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5479	159.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	462	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1519	90.8	1	SNP	p	V57M	1	.	.	169	171	ATG	697	699	ATG	179;179;180	A;T;G	165;160;163	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
